Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies
In recent years, there has been an increasing interest in oncolytic adenoviral vectors as an alternative anticancer therapy. The induction of an immune response can be considered as a major limitation of this kind of application. Significant research efforts have been focused on the development of b...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/10/2565 |
id |
doaj-62fbb2ac4d2c4a90a237708261185979 |
---|---|
record_format |
Article |
spelling |
doaj-62fbb2ac4d2c4a90a2377082611859792020-11-25T00:47:08ZengMDPI AGMolecules1420-30492018-10-012310256510.3390/molecules23102565molecules23102565Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing AntibodiesIbrahim R. Khalil0Martin P. Khechara1Sathishkumar Kurusamy2Angel L. Armesilla3Abhishek Gupta4Barbara Mendrek5Tamara Khalaf6Mariastella Scandola7Maria Letizia Focarete8Marek Kowalczuk9Iza Radecka10Wolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKWolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKWolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKWolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKWolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKCentre of Polymer and Carbon Materials, Polish Academy of Sciences, ul. M. Curie-Skłodowskiej 34, 41-819 Zabrze, PolandWolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKDepartment of Chemistry ′G. Ciamician′ and National Consortium of Materials Science and Technology (INSTM, Bologna RU), Alma Mater Studiorum–Università di Bologna Via Selmi 2, 40126 Bologna, ItalyDepartment of Chemistry ′G. Ciamician′ and National Consortium of Materials Science and Technology (INSTM, Bologna RU), Alma Mater Studiorum–Università di Bologna Via Selmi 2, 40126 Bologna, ItalyWolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKWolverhampton School of Sciences, Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UKIn recent years, there has been an increasing interest in oncolytic adenoviral vectors as an alternative anticancer therapy. The induction of an immune response can be considered as a major limitation of this kind of application. Significant research efforts have been focused on the development of biodegradable polymer poly-gamma-glutamic acid (γ-PGA)-based nanoparticles used as a vector for effective and safe anticancer therapy, owing to their controlled and sustained-release properties, low toxicity, as well as biocompatibility with tissue and cells. This study aimed to introduce a specific destructive and antibody blind polymer-coated viral vector into cancer cells using γ-PGA and chitosan (CH). Adenovirus was successfully encapsulated into the biopolymer particles with an encapsulation efficiency of 92% and particle size of 485 nm using the ionic gelation method. Therapeutic agents or nanoparticles (NPs) that carry therapeutics can be directed specifically to cancerous cells by decorating their surfaces using targeting ligands. Moreover, in vitro neutralizing antibody response against viral capsid proteins can be somewhat reduced by encapsulating adenovirus into γ-PGA-CH NPs, as only 3.1% of the encapsulated adenovirus was detected by anti-adenovirus antibodies in the presented work compared to naked adenoviruses. The results obtained and the unique characteristics of the polymer established in this research could provide a reference for the coating and controlled release of viral vectors used in anticancer therapy.http://www.mdpi.com/1420-3049/23/10/2565biodegradable polymerγ-PGAchitosanadenovirusimmunogenicity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ibrahim R. Khalil Martin P. Khechara Sathishkumar Kurusamy Angel L. Armesilla Abhishek Gupta Barbara Mendrek Tamara Khalaf Mariastella Scandola Maria Letizia Focarete Marek Kowalczuk Iza Radecka |
spellingShingle |
Ibrahim R. Khalil Martin P. Khechara Sathishkumar Kurusamy Angel L. Armesilla Abhishek Gupta Barbara Mendrek Tamara Khalaf Mariastella Scandola Maria Letizia Focarete Marek Kowalczuk Iza Radecka Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies Molecules biodegradable polymer γ-PGA chitosan adenovirus immunogenicity |
author_facet |
Ibrahim R. Khalil Martin P. Khechara Sathishkumar Kurusamy Angel L. Armesilla Abhishek Gupta Barbara Mendrek Tamara Khalaf Mariastella Scandola Maria Letizia Focarete Marek Kowalczuk Iza Radecka |
author_sort |
Ibrahim R. Khalil |
title |
Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies |
title_short |
Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies |
title_full |
Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies |
title_fullStr |
Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies |
title_full_unstemmed |
Poly-Gamma-Glutamic Acid (γ-PGA)-Based Encapsulation of Adenovirus to Evade Neutralizing Antibodies |
title_sort |
poly-gamma-glutamic acid (γ-pga)-based encapsulation of adenovirus to evade neutralizing antibodies |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2018-10-01 |
description |
In recent years, there has been an increasing interest in oncolytic adenoviral vectors as an alternative anticancer therapy. The induction of an immune response can be considered as a major limitation of this kind of application. Significant research efforts have been focused on the development of biodegradable polymer poly-gamma-glutamic acid (γ-PGA)-based nanoparticles used as a vector for effective and safe anticancer therapy, owing to their controlled and sustained-release properties, low toxicity, as well as biocompatibility with tissue and cells. This study aimed to introduce a specific destructive and antibody blind polymer-coated viral vector into cancer cells using γ-PGA and chitosan (CH). Adenovirus was successfully encapsulated into the biopolymer particles with an encapsulation efficiency of 92% and particle size of 485 nm using the ionic gelation method. Therapeutic agents or nanoparticles (NPs) that carry therapeutics can be directed specifically to cancerous cells by decorating their surfaces using targeting ligands. Moreover, in vitro neutralizing antibody response against viral capsid proteins can be somewhat reduced by encapsulating adenovirus into γ-PGA-CH NPs, as only 3.1% of the encapsulated adenovirus was detected by anti-adenovirus antibodies in the presented work compared to naked adenoviruses. The results obtained and the unique characteristics of the polymer established in this research could provide a reference for the coating and controlled release of viral vectors used in anticancer therapy. |
topic |
biodegradable polymer γ-PGA chitosan adenovirus immunogenicity |
url |
http://www.mdpi.com/1420-3049/23/10/2565 |
work_keys_str_mv |
AT ibrahimrkhalil polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT martinpkhechara polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT sathishkumarkurusamy polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT angellarmesilla polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT abhishekgupta polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT barbaramendrek polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT tamarakhalaf polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT mariastellascandola polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT marialetiziafocarete polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT marekkowalczuk polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies AT izaradecka polygammaglutamicacidgpgabasedencapsulationofadenovirustoevadeneutralizingantibodies |
_version_ |
1725261679735865344 |